Sign In

Katherine Harris

Chief Development Officer | Board Director

Katherine Harris is a prominent figure in the field of antibody research and development, currently serving as a Board Member of The Antibody Society. Here's a comprehensive overview of her professional background and involvement with the organization:

Professional Experience

Katherine Harris is currently the Chief Development Officer (CDO) at Rondo Therapeutics, a position she has held since February 2023.3 In this role, she:

  • Leads IND-enabling activities, including CMC, toxicology, pharmacology, DMPK, and regulatory aspects
  • Provides strategic guidance on target selection and program prioritization
  • Oversees non-clinical development plans from candidate nomination through IND submission
  • Manages external partnerships related to non-clinical development

Prior to her current position, Harris held several leadership roles in the biotechnology industry:

  • Vice President of Discovery at Amgen (October 2021 - February 2023)
  • Vice President and Senior Director of Discovery at Teneobio, Inc. (2017 - 2021)
  • Senior Research Scientist at Teneobio, Inc. (2015 - 2017)
  • Research Scientist at Panoply Bio and SwitchGear Genomics (2011 - 2015)

Education

Harris holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley (2001-2007) and a B.S. in Biology from the University of Missouri-Kansas City (1999-2000).3

Involvement with The Antibody Society

Katherine Harris has been actively involved with The Antibody Society in various capacities:

  1. Board Member: Recently elected to the Board of Directors of The Antibody Society.56

  2. Vice President: Serving as the Vice President of The Antibody Society for the 2024-25 term.1

  3. Meetings Committee Chair: Harris chairs the Meetings Committee of The Antibody Society.27

  4. Scientific Advisor: She serves as a scientific advisor for the Antibody Engineering & Therapeutics Europe conference.2

In her role with The Antibody Society, Harris contributes to the organization's mission of advancing antibody research and development. Her expertise in IND-enabling activities and preclinical drug development is particularly valuable to the society's goals.45

Katherine Harris's LinkedIn username is indeed "katharris".3

Highlights

The Antibody Society Archives
The Antibody Society announces the election of new Directors and ...

Related Questions

What are Katherine Harris's main responsibilities at Rondo Therapeutics?
How did Katherine Harris transition from Amgen to Rondo Therapeutics?
What is Katherine Harris's educational background?
What are some notable achievements of Katherine Harris in her career?
How has Katherine Harris contributed to The Antibody Society?
Katherine Harris
Katherine Harris, photo 1
Katherine Harris, photo 2
Add to my network

Location

San Francisco Bay Area